Brief: Biofrontera Says On Sept 13, Co Served With Complaint Filed In U.S. District Court By DUSA

Biofrontera

03/10/2023 22:51

Oct 3 (Reuters) - Biofrontera Inc  BFRI.O :
    * BIOFRONTERA- ON SEPT 13, CO WAS SERVED WITH COMPLAINT
FILED IN
U.S. DISTRICT COURT FOR DISTRICT OF MASSACHUSETTS BY DUSA
PHARMACEUTICALS INC
    * BIOFRONTERA- ON SEPT 13, CO WAS SERVED WITH COMPLAINT
FILED IN
U.S. DISTRICT COURT FOR DISTRICT OF MASSACHUSETTS BY  SUN
PHARMACEUTICAL INDUSTRIES
    * BIOFRONTERA-ON SEPT 13, CO WAS SERVED WITH COMPLAINT FILED
IN
U.S. DISTRICT COURT FOR DISTRICT OF MASSACHUSETTS BY   SUN
PHARMACEUTICAL INDUSTRIES LTD
    * BIOFRONTERA- IN COMPLAINT DUSA PHARMACEUTICALS ALLEGES
BREACH OF
CONTRACT, VIOLATION OF THE LANHAM ACT, AND UNFAIR TRADE
PRACTICES
    * BIOFRONTERA- COMPANY DENIES THE PLAINTIFFS’ CLAIMS AND
INTENDS
TO DEFEND THESE MATTERS "VIGOROUSLY"
    * BIOFRONTERA-  ALL CLAIMS STEM FROM ALLEGATIONS THAT CO HAS
PROMOTED ITS AMELUZ PRODUCT IN A MANNER THAT IS INCONSISTENT
WITH ITS APPROVED FDA LABELING
    * BIOFRONTERA- IN COMPLAINT SUN PHARMACEUTICAL INDUSTRIES
INC
ALLEGES BREACH OF CONTRACT, VIOLATION OF LANHAM ACT, UNFAIR
TRADE PRACTICES
    * BIOFRONTERA- IN COMPLAINT SUN PHARMACEUTICAL INDUSTRIES
LTD
ALLEGES BREACH OF CONTRACT, VIOLATION OF LANHAM ACT, UNFAIR
TRADE PRACTICES

Source text for Eikon:  ID: 
Further company coverage:  BFRI.O 

 ((Reuters.Briefs@thomsonreuters.com;))